Phase 1 Study of Betalutin for Diffuse Large B-cell Lymphoma Gets Underway
News
A Phase 1 trial evaluating Betalutin, an anti-CD37 antibody attached to a radioactive compound, in patients with relapsed diffuse large B-cell lymphoma (DLBCL) has dosed its first participant. The trial ... Read more